Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR2554 and SHR1701 in Advanced Solid Tumors and B-cell Lymphomas
NCT04407741Phase 2Recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Sep 2020
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of zeprumetostat in solid tumor and B cell lymphoma, sponsored by Chinese PLA General Hospital. Started Sep 2020; status: recruiting.
02
Drugs
zeprumetostat
03
Conditions
solid tumorB cell lymphoma
Beyond the preview
Go deeper on NCT04407741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04407741.